Personal tools

Coexpression cluster:C426

From FANTOM5_SSTAR

Revision as of 15:03, 13 July 2012 by Autoedit (talk | contribs)
Jump to: navigation, search


Full id: C426_CD4_CD14_Neutrophils_CD8_Natural_Mast_Eosinophils



Phase1 CAGE Peaks

Hg19::chr14:35871591..35871602,-p@chr14:35871591..35871602
-
Hg19::chr4:103480333..103480371,+p@chr4:103480333..103480371
+
Hg19::chr4:103496453..103496481,+p@chr4:103496453..103496481
+
Hg19::chr4:103498478..103498489,+p12@NFKB1
Hg19::chr4:103498623..103498650,+p9@NFKB1
Hg19::chr6:138189104..138189115,+p@chr6:138189104..138189115
+
Hg19::chr6:138189215..138189247,+p@chr6:138189215..138189247
+
Hg19::chr6:138190239..138190250,+p@chr6:138190239..138190250
+
Hg19::chr6:138192331..138192343,+p10@TNFAIP3
Hg19::chr6:138192345..138192366,+p11@TNFAIP3
Hg19::chr6:138192426..138192438,+p12@TNFAIP3
Hg19::chr6:138192543..138192555,+p13@TNFAIP3
Hg19::chr6:138196020..138196034,+p8@TNFAIP3
Hg19::chr6:138196838..138196867,+p16@TNFAIP3
Hg19::chr6:138197180..138197238,+p9@TNFAIP3
Hg19::chr6:138198202..138198217,+p@chr6:138198202..138198217
+
Hg19::chr6:138198297..138198311,+p@chr6:138198297..138198311
+
Hg19::chr6:138198346..138198366,+p@chr6:138198346..138198366
+
Hg19::chr6:138199895..138199908,+p@chr6:138199895..138199908
+
Hg19::chr6:138199945..138199956,+p@chr6:138199945..138199956
+
Hg19::chr6:138201273..138201294,+p@chr6:138201273..138201294
+
Hg19::chr6:138204018..138204028,+p@chr6:138204018..138204028
+
Hg19::chr6:138204056..138204068,+p@chr6:138204056..138204068
+
Hg19::chr7:138766106..138766122,-p@chr7:138766106..138766122
-


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


p.valueFDRnGenesnPathwayName
4.19956876000442e-060.0026583270250828259NOD-like receptor signaling pathway (KEGG):04621
2.18716290008179e-050.004052278519474552134Measles (KEGG):05162
0.0007705509155556930.0487758729546754111Osteopontin Signaling (Wikipathways):WP1434
2.38818258532104e-050.004052278519474552140Regulation of toll-like receptor signaling pathway (Wikipathways):WP1449
0.000560430119292420.044344033189012718TFs Regulate miRNAs related to cardiac hypertrophy (Wikipathways):WP1559
4.31443715156972e-050.004551731194906062188TNF-alpha/NF-kB Signaling Pathway (Wikipathways):WP231
0.0003198274735665560.02892154153823282511Signaling in Immune system (Reactome):REACT_6900
0.000649516938528610.04568269134317892728TNF alpha/NF-kB up reg. targets (Netpath):NetPath_9
3.20085191111734e-050.004052278519474552162TNF alpha/NF-kB down reg. targets (Netpath):NetPath_9
2.92938943019595e-050.004052278519474552155IL-1 up reg. targets (Netpath):NetPath_13



Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data


GO IDGO nameFDR corrected p-value
GO:0006916anti-apoptosis0.0012626724630421
GO:0043066negative regulation of apoptosis0.0012626724630421
GO:0043069negative regulation of programmed cell death0.0012626724630421
GO:0042981regulation of apoptosis0.00476396946754751
GO:0043067regulation of programmed cell death0.00476396946754751
GO:0043124negative regulation of I-kappaB kinase/NF-kappaB cascade0.00488601741722185
GO:0006915apoptosis0.00592300066246309
GO:0012501programmed cell death0.00592300066246309
GO:0016265death0.00592300066246309
GO:0008219cell death0.00592300066246309
GO:0048523negative regulation of cellular process0.00836632581832125
GO:0048519negative regulation of biological process0.00836632581832125
GO:0048468cell development0.00852704727292275
GO:0048869cellular developmental process0.0156990917752577
GO:0030154cell differentiation0.0156990917752577
GO:0009968negative regulation of signal transduction0.030993977189682
GO:0043122regulation of I-kappaB kinase/NF-kappaB cascade0.030993977189682
GO:0007249I-kappaB kinase/NF-kappaB cascade0.0376570466175902
GO:0032502developmental process0.0423912959518589
GO:0003677DNA binding0.0441894487628634



Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>


Cell Type
Ontology termp-valuen
leukocyte6.82e-37140
nongranular leukocyte8.55e-28119
hematopoietic lineage restricted progenitor cell2.60e-26124
hematopoietic stem cell2.66e-26172
angioblastic mesenchymal cell2.66e-26172
hematopoietic cell4.89e-24182
hematopoietic oligopotent progenitor cell6.47e-24165
hematopoietic multipotent progenitor cell6.47e-24165
CD14-positive, CD16-negative classical monocyte2.80e-2242
myeloid leukocyte6.97e-2276
classical monocyte4.12e-2045
granulocyte monocyte progenitor cell1.99e-1871
macrophage dendritic cell progenitor6.44e-1865
monopoietic cell7.40e-1763
monocyte7.40e-1763
monoblast7.40e-1763
promonocyte7.40e-1763
myeloid lineage restricted progenitor cell4.77e-1670
myeloid cell4.41e-14112
common myeloid progenitor4.41e-14112
lymphocyte1.03e-0953
common lymphoid progenitor1.03e-0953
lymphoid lineage restricted progenitor cell1.88e-0952
multi fate stem cell8.86e-08430
somatic stem cell9.47e-08436
mesenchymal cell1.15e-07358
T cell1.29e-0725
pro-T cell1.29e-0725
stem cell1.57e-07444
Uber Anatomy
Ontology termp-valuen
hematopoietic system2.37e-18102
blood island2.37e-18102
hemolymphoid system4.52e-18112
bone marrow4.67e-1480
bone element7.42e-1286
immune system2.03e-11115
lateral plate mesoderm2.33e-09216
skeletal element2.47e-08101
skeletal system2.47e-08101
musculoskeletal system2.81e-07167


Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs



JASPAR motifs

Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}



ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data


No analysis results for this cluster

Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data


This analysis result is provided for C0 - C305 clusters.